C-Reactive Protein Predicts Incidence of Dementia in an Elderly Asian Community Cohort

Journal of the American Medical Directors Association

Volumn 18, Issue 3, 2017, Pages 277.e7-277.e11

  Hsu, Pai Feng ^a,b   Pan, Wen Harn ^c,d   Yip, Bak Sau ^e   Chen, Rosalind Chia Yu ^d   Cheng, Hao Min ^a,b   Chuang, Shao Yuan ^d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c ACADEMIA SINICA   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

C reactive protein; competing risk; dementia incidence

Indexed keywords

C REACTIVE PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; ASIAN; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMMUNITY CARE; DEMENTIA; DISEASE ASSOCIATION; FEMALE; HUMAN; ICD-9; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NONVASCULAR DEMENTIA; PROSPECTIVE STUDY; ASIAN CONTINENTAL ANCESTRY GROUP; PREDICTIVE VALUE; TAIWAN;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; C-REACTIVE PROTEIN; DEMENTIA; FEMALE; HUMANS; INCIDENCE; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TAIWAN;

EID: 85011051630     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2016.12.006     Document Type: Article

References (32)

1. 1 Gorelick, P.B., Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann N Y Acad Sci 1207 (2010), 155–162.
2. 2 Breitner, J.C., Baker, L.D., Montine, T.J., et al. Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimers Dement 7 (2011), 402–411.
3. 3 Eikelenboom, P., van Exel, E., Hoozemans, J.J., et al. Neuroinflammation: an early event in both the history and pathogenesis of Alzheimer's disease. Neurodegener Dis 7 (2010), 38–41.
4. 4 Casserly, I., Topol, E., Convergence of atherosclerosis and Alzheimer's disease: Inflammation, cholesterol, and misfolded proteins. Lancet 363 (2004), 1139–1146.
5. 5 Pradhan, A.D., Manson, J.E., Rifai, N., et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286 (2001), 327–334.
6. 6 Engelhart, M.J., Geerlings, M.I., Meijer, J., et al. Inflammatory proteins in plasma and the risk of dementia: The Rotterdam study. Arch Neurol 61 (2004), 668–672.
7. 7 Makar, A.B., McMartin, K.E., Palese, M., Tephly, T.R., Formate assay in body fluids: Application in methanol poisoning. Biochem Med 13 (1975), 117–126.
8. 8 Eriksson, U.K., Pedersen, N.L., Reynolds, C.A., et al. Associations of gene sequence variation and serum levels of C-reactive protein and interleukin-6 with Alzheimer's disease and dementia. J Alzheimers Dis 23 (2011), 361–369.
9. 9 Schmidt, R., Schmidt, H., Curb, J.D., et al. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 52 (2002), 168–174.
10. 10 Sundelof, J., Kilander, L., Helmersson, J., et al. Systemic inflammation and the risk of Alzheimer's disease and dementia: A prospective population-based study. J Alzheimers Dis 18 (2009), 79–87.
11. 11 Ravaglia, G., Forti, P., Maioli, F., et al. Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging. Neurobiol Aging 28 (2007), 1810–1820.
12. 12 Chei, C.L., Yamagishi, K., Ikeda, A., et al. C-reactive protein levels and risk of disabling dementia with and without stroke in Japanese: The Circulatory Risk in Communities Study (CIRCS). Atherosclerosis 236 (2014), 438–443.
13. 13 Pan, W.H., Hung, Y.T., Shaw, N.S., et al. Elderly Nutrition and Health Survey in Taiwan (1999–2000): Research design, methodology and content. Asia Pac J Clin Nutr 14 (2005), 203–210.
14. 14 Janssen, I., Heymsfield, S.B., Baumgartner, R.N., Ross, R., Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol (1985) 89 (2000), 465–471.
15. 15 Chien, M.Y., Huang, T.Y., Wu, Y.T., Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. J Am Geriatr Soc 56 (2008), 1710–1715.
16. 16 Fine, J.P., Gray, R.J., A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94 (1999), 496–509.
17. 17 Varadhan, R., Weiss, C.O., Segal, J.B., et al. Evaluating health outcomes in the presence of competing risks: A review of statistical methods and clinical applications. Med Care 48 (2010), S96–S105.
18. 18 Dik, M.G., Jonker, C., Hack, C.E., et al. Serum inflammatory proteins and cognitive decline in older persons. Neurology 64 (2005), 1371–1377.
19. 19 van Himbergen, T.M., Beiser, A.S., Ai, M., et al. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and Alzheimer disease: Results from the Framingham Heart Study. Arch Neurol 69 (2012), 594–600.
20. 20 Koyama, A., O'Brien, J., Weuve, J., et al. The role of peripheral inflammatory markers in dementia and Alzheimer's disease: A meta-analysis. J Gerontol A Biol Sci Med Sci 68 (2013), 433–440.
21. 21 Johar, H., Kawan, R., Emeny, R.T., Ladwig, K.H., Impaired sleep predicts cognitive decline in old people: Findings from the Prospective KORA Age Study. Sleep 39 (2016), 217–226.
22. 22 Almondes, K.M., Costa, M.V., Malloy-Diniz, L.F., Diniz, B.S., Insomnia and risk of dementia in older adults: Systematic review and meta-analysis. J Psychiatr Res 77 (2016), 109–115.
23. 23 O'Donnell, J., Ding, F., Nedergaard, M., Distinct functional states of astrocytes during sleep and wakefulness: Is norepinephrine the master regulator?. Curr Sleep Med Rep 1 (2015), 1–8.
24. 24 Qiu, C., Winblad, B., Fratiglioni, L., The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4 (2005), 487–499.
25. 25 Jagoda, A., Pietrzak, M., Hazen, S., Vayer, J., Prehospital care and the military. Mil Med 157 (1992), 11–15.
26. 26 Skoog, I., Lernfelt, B., Landahl, S., et al. 15-year longitudinal study of blood pressure and dementia. Lancet 347 (1996), 1141–1145.
27. 27 Ruitenberg, A., Skoog, I., Ott, A., et al. Blood pressure and risk of dementia: Results from the Rotterdam study and the Gothenburg H-70 Study. Dement Geriatr Cogn Disord 12 (2001), 33–39.
28. 28 Morris, M.C., Scherr, P.A., Hebert, L.E., et al. Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol 58 (2001), 1640–1646.
29. 29 Verghese, J., Lipton, R.B., Hall, C.B., et al. Low blood pressure and the risk of dementia in very old individuals. Neurology 61 (2003), 1667–1672.
30. 30 Qiu, C., von Strauss, E., Fastbom, J., et al. Low blood pressure and risk of dementia in the Kungsholmen project: A 6-year follow-up study. Arch Neurol 60 (2003), 223–228.
31. 31 Mukamal, K.J., Kuller, L.H., Fitzpatrick, A.L., et al. Prospective study of alcohol consumption and risk of dementia in older adults. JAMA 289 (2003), 1405–1413.
32. 32 Ilomaki, J., Jokanovic, N., Tan, E.C., Lonnroos, E., Alcohol consumption, dementia and cognitive decline: An overview of systematic reviews. Curr Clin Pharmacol 10 (2015), 204–212.